Search form

You are here

Portfolio

3CTN supports a portfolio of academic clinical trials that reflect the priorities of clinicians, researchers, patients, ministries of health and funders. Scientific oversight will be provided by the Portfolio Committee (PC) and management of the day-to-day operations is provided by the 3CTN Coordinating Centre. Academically sponsored trials that are included on the portfolio are eligible for 3CTN support.

3CTN aims to assist both clinicians/researchers and patients in finding cancer clinical trials that may be of benefit. Patients that are interested in participating in a clinical trial must contact their healthcare provider for details, but may wish to search the 3CTN Portfolio to know which trials are open to accrual at their local centre.

Once a trial has been assessed (as per the diagram above) and accepted on to the 3CTN Portfolio, a Network centre that has the opened the trial to accrual is eligible* to receive per case funding (PCF) for any patient recruitment above the established baseline recruitment** for that centre

*subject to their individual contractual agreements between 3CTN and the Network site

** established baseline recruitment is defined in the individual contractual agreements between 3CTN and the Network site

How much per case funding (PCF) will the site receive?

All trials on the 3CTN Portfolio are assessed for complexity and assigned a complexity category (Low, Standard, or High) based on the 3CTN Trial Weighting System (see Trial Weighting System documents). The PCF amount associated with each complexity rating is listed in the table below:

Raw Score

Range

PCF Amount($)

0-3

Low

1,000

4-6

Standard

1,500

7 or more

High

2,000

Who do I contact for more information about the 3CTN Portfolio or the trial application process?